vmp001
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2010 (NCT01157897)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Plasmodium vivaxImmunity, active
Plasmodium vivax immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vmp001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01157897 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2010 | Department of Defense, GlaxoSmithKline, PATH, United States Army |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Department of Defense | Government | 1 | 0 | 1 | 2010 |
| GlaxoSmithKline | For profit | 1 | 0 | 1 | 2010 |
| PATH | Academic/Hospital | 1 | 0 | 1 | 2010 |
| United States Army | Government | 1 | 1 | 1 | 2010 |
4 organizations
Page 1 / 1